Amdepin Duo

Quick links

Choose a section

Quick links to important sections

Advertisements
Advertisements

Overview of Amdepin Duo

Quick Facts

Property Description
Active ingredients Amlodipine (besylate), Atorvastatin (calcium)
Form Fixed-dose combination tablet
Pharmacological class Antihypertensive/Antihyperlipidemic Agent Combination
Common use Management of high blood pressure and high cholesterol
Origin Synthetic compounds

1. Defining Amdepin Duo: A Fixed-Dose Combination (FDC)

Amdepin Duo is a synthetic, prescription-only fixed-dose combination (FDC) medicine formulated as an oral tablet for adult patients. This FDC is officially classified as an Antihypertensive/Antihyperlipidemic Agent Combination, reflecting its dual role in managing two critical cardiovascular risk factors. This combination is clinically recognized for offering a streamlined approach to patients requiring simultaneous therapy for these co-existing conditions.

The primary benefit of using a fixed-dose combination is the simplification of the treatment regimen, which aids long-term adherence for individuals needing therapeutic doses of both compounds. Other popular analogue brands utilize the same Amlodipine and Atorvastatin formulation, positioning Amdepin Duo within a successful class of dual-action tablets.

2. Amdepin Duo's Composition: Amlodipine and Atorvastatin

The Amdepin Duo composition is built upon two active ingredients: Amlodipine besylate and Atorvastatin calcium. These chemical substances belong to two different major pharmacological classes. Amlodipine is an antihypertensive agent categorized as a dihydropyridine calcium channel blocker, while Atorvastatin is a lipid-lowering agent belonging to the HMG-CoA reductase inhibitor class (Statin).

The pairing of these two classes creates a dual-action therapy that provides synergistic effects against cardiovascular risk factors. This structural integrity means the oral tablet provides complementary physiological actions by addressing vascular tone and cholesterol production simultaneously, a key differentiation from single-agent drugs.

Advertisements

What side effects are possible with Amdepin Duo?

Possible Side Effects and Safety Information

The safety profile of Amdepin Duo, a fixed-dose combination of amlodipine and atorvastatin, is based on the documented adverse reactions and limitations listed in official regulatory prescribing information. Adverse effects are formally categorized by frequency (e.g., Common, Rare) and the System-Organ Class (SOC) affected.

Documented Adverse Reactions

Adverse reactions classified as Common (potentially affecting up to 1 in 10 people) typically involve the Nervous System and Gastrointestinal System. These frequently reported effects include headache, dizziness, somnolence (drowsiness), myalgia (muscle pain), abdominal pain, and peripheral edema (swelling). The occurrence of swelling is noted in regulatory documents as potentially more frequent at the start of treatment, particularly in older adults.

Serious Safety Concerns and Restrictions

Serious adverse reactions listed in official labeling include rare but significant events related to the atorvastatin component, such as rhabdomyolysis (severe muscle breakdown) and hepatic failure (liver failure). The risk of severe muscle-related events is officially associated with increased doses of the atorvastatin component.

Specific regulatory constraints prohibit the use of Amdepin Duo in certain populations. The medicine is contraindicated in individuals with active liver disease and is strictly prohibited for women who are or may become pregnant or who are breastfeeding, due to safety concerns documented in the official prescribing information.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for an overdose of Amdepin Duo is defined by the known risks associated with its two active components, mandating immediate emergency response.

Overdosage of the Amlodipine component may lead to severe cardiovascular manifestations, primarily marked and potentially prolonged systemic hypotension and excessive peripheral vasodilation. A compensatory response such as reflex tachycardia may occur. Due to the extent of these effects, severe cases carry an officially documented risk of cardiovascular shock with a fatal outcome. The Atorvastatin component is generally not associated with specific, identifiable clinical signs of overdosage.

Mandated Emergency Actions

It is a regulatory requirement to seek immediate medical attention or contact emergency services immediately upon the suspicion of overdose. This urgent action is necessary due to the life-threatening potential of profound hypotension.

There is no specific antidote known or documented to reverse the effects of either component. Overdose management is officially defined as being symptomatic and supportive. This includes providing active cardiovascular support for hypotension, such as the administration of intravenous fluids and vasopressors, and may involve using calcium gluconate. Procedures like gastric lavage or administering activated charcoal may also be considered in cases of recent ingestion to limit absorption. Continuous cardiac and respiratory monitoring in a hospital setting is required for observation.

Advertisements

Therapeutic Uses of Amdepin Duo

What Amdepin Duo Treats: Main Uses and Benefits

The primary therapeutic use of Amdepin Duo is the simultaneous management of two critical cardiovascular risk factors: persistent high blood pressure (hypertension) and abnormally elevated cholesterol levels (dyslipidemia). This fixed-dose combination is generally considered appropriate for adult patients requiring treatment with both components. The medication is commonly used across conditions presenting with systemic imbalance, including hypertension, dyslipidemia, chronic stable angina, and angiographically documented Coronary Artery Disease.

Comprehensive Treatment for Co-existing Risk Factors

The medication is applied to address symptom clusters that may become disruptive, such as the strain created by high blood pressure, and to manage the metabolic stress of high cholesterol. The main therapeutic benefit contributes to long-term management of conditions marked by increased physiological stress; it plays a role in the continued stability of the cardiovascular system and is relevant in situations involving certain distressing symptoms.

Enhancing Comfort in Chronic Vascular Challenges

The medication is considered relevant for easing symptoms related to chronic stable angina pectoris—recurrent chest discomfort associated with reduced blood supply to the heart. It also supports the patient by managing symptoms that interfere with daily comfort related to Coronary Artery Disease. This supportive action helps maintain a sense of stability when symptoms are more noticeable.


Quick Fact: Relief for Chronic Vascular Stress

Amdepin Duo is commonly used to manage the long-term physiological stress associated with both persistent high blood pressure and chronic imbalances in cholesterol levels. This dual-action approach supports patients during phases where the continuous burden of these conditions affects overall stability.

Advertisements

Eligibility and Restrictions for Use

Official Eligibility and Contraindications

Amdepin Duo, a combination of amlodipine and atorvastatin, is contraindicated and must not be used by specific patient groups, as defined by regulatory documents.

Contraindicated Populations (Must Not Use):

  • Patients with known hypersensitivity or allergy to amlodipine, atorvastatin, dihydropyridine derivatives, or any component of the tablet.
  • Patients with active liver disease, acute liver failure, decompensated cirrhosis, or those with unexplained persistent elevations of serum transaminases (abnormal liver tests).
  • Women who are pregnant or who may become pregnant, as the atorvastatin component may cause fetal harm. Reliable contraception is required for women of childbearing age.

Restricted or Special Consideration Required:

  • Pregnancy and Lactation: Use is generally not recommended during pregnancy or while breastfeeding.
  • Age: Use is restricted to adults and pediatric patients aged 10 years or older with certain hypercholesterolemia types. Safety and efficacy are not established in children younger than 10 years.
  • Clinical Status: Special caution is required for patients with severe hypotension (very low blood pressure), severe aortic stenosis, recent stroke, uncontrolled hypothyroidism, alcoholism, or a history of muscle problems (myopathy).
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official Interaction Profile

Amdepin Duo, a fixed-dose combination of Amlodipine and Atorvastatin, has an interaction profile primarily characterized by factors that alter the systemic exposure of the Atorvastatin component. This exposure change is the basis for regulatory restrictions established by official authorities like the FDA and EMA.

Pharmacokinetic and Pharmacodynamic Effects

Many documented drug interactions result from the inhibition of the CYP3A4 enzyme or drug transporters such as OATP1B1 and BCRP. Co-administration with strong CYP3A4 inhibitors, including certain antivirals or macrolides (e.g., Clarithromycin), necessitates specific limitations on the daily statin dose due to the increased plasma concentration of Atorvastatin.

Pharmacodynamic interactions involve substances that cause an additive risk of myopathy or rhabdomyolysis, independent of the metabolic pathway. These substances include Colchicine, other fibrates, and lipid-modifying doses of Niacin (greater than 1 g/day).

Restrictions and Contraindicated Combinations

Official labeling documents formally not recommended combinations due to significant interaction risk, including Cyclosporine, Gemfibrozil, and certain Hepatitis C Antivirals. Furthermore, consumption of large quantities of Grapefruit Juice is restricted, and consumption of large amounts of alcohol is linked to an increased risk of liver damage. Co-administration with Rifampin is required to be simultaneous, as delayed administration significantly reduces the statin component's effectiveness.

Advertisements

Mechanism of Action

Amdepin Duo incorporates two distinct, complementary mechanisms to influence cardiovascular function, acting on both vascular mechanics and lipid biochemistry simultaneously.

Calcium Channel Blockade and Vascular Relaxation

Amlodipine works by blocking the L-type voltage-dependent calcium channels ( L-VDCCs) found on arterial smooth muscle cells. This action prevents the influx of extracellular calcium ions, which are essential for initiating muscle contraction. By inhibiting this signaling sequence, Amlodipine causes the blood vessels to widen (vasodilate), leading to a direct reduction in Total Peripheral Resistance ( TPR).

HMG-CoA Reductase Inhibition and Lipid Homeostasis

Atorvastatin acts by inhibiting the HMG-CoA reductase enzyme, the key rate-limiting step in the liver's mevalonate pathway for cholesterol synthesis. This blockade lowers the liver’s internal cholesterol production, triggering an increase in LDL receptors on the liver cell surface. This compensatory mechanism enhances the liver's capacity to remove more Low-Density Lipoprotein Cholesterol ( LDL-C) from the bloodstream, leading to a net modulation of serum lipid concentration.

Dual Pathway Synergy and Endothelial Modulation

The combination incorporates dual physiological actions: Amlodipine modulates hemodynamic pressure while Atorvastatin modulates biochemical lipid load. Atorvastatin also provides pleiotropic effects, actions independent of lipid lowering, by modulating endothelial function and modulation of inflammatory mediators within the vascular wall, and works alongside Amlodipine’s direct physical vasodilation.

Advertisements

Dosage and Administration Information

How to Use Amdepin Duo: Official Administration Guidelines

The usage of Amdepin Duo is governed by standardized instructions defining its high-level administration protocol. This medicine is a fixed-dose combination (FDC) designed for once-daily, oral administration. It is supplied as a tablet that should be swallowed whole and can be taken with or without food at any time of the day, simplifying its incorporation into a daily routine.


Standard Dosing and Titration

Official labeling defines specific initial dose ranges for the components (Amlodipine and Atorvastatin) and establishes clear rules for adjustment. The typical initial dose for the Amlodipine component is 5 mg once daily, with the maximum dose set at 10 mg once daily. For the Atorvastatin component, the starting range is typically 10 mg to 20 mg once daily, with a maximum dose of 80 mg once daily. Treatment is intended for long-term chronic management. Dose changes, known as titration, are not frequent; the Amlodipine dose is typically adjusted over intervals of 7 to 14 days, while the Atorvastatin component's dose is reviewed and adjusted based on lipid levels over intervals of 4 weeks or more.


Population-Specific Use and Instructions

Specific starting dose instructions are outlined for certain adult patient groups. A lower initial dose of 2.5 mg of the Amlodipine component is specified for small, fragile, elderly patients or those with hepatic impairment. Dosage adjustment for the Atorvastatin component is not necessary in patients with renal dysfunction. If a dose is missed, patients are advised not to take the missed dose and to resume with the next scheduled dose.

Advertisements

Recent Clinical Evidence

Amdepin Duo is a fixed-dose combination (FDC) therapy containing amlodipine (a calcium channel blocker) and atorvastatin (a statin). Clinical research on this combination primarily focuses on patients with coexisting hypertension (high blood pressure) and dyslipidemia (high cholesterol), two significant, interconnected cardiovascular risk factors.

Efficacy in Cardiovascular Risk Reduction

Clinical trials have investigated the co-administration of amlodipine and atorvastatin in managing these dual risk factors. A key finding from studies like the AVALON trial demonstrated that co-administered treatment regimens were associated with a significant decrease in Framingham-estimated 10-year risk of coronary heart disease among participants with both conditions. Furthermore, research has tracked patients who achieved both their target blood pressure and target low-density lipoprotein cholesterol (LDL-C) goals, noting that a higher percentage of patients on the combination therapy achieved these dual targets compared to those on either monotherapy or placebo.

Safety and Tolerability

Study findings generally suggest that the side effect profile of the fixed-dose combination is comparable to that of the individual components taken separately. This indicates that combining the two agents into a single tablet does not introduce new or unexpected safety concerns. However, some studies have noted that higher doses of atorvastatin, one component of the combination, may be associated with an increased risk of new-onset diabetes, though the cardiovascular benefits typically outweigh this risk.

Fixed-Dose Combination vs. Free Combination

Research has explored the effect of fixed-dose combination regimens on patient adherence. Studies suggest that the FDC may lead to improved medication adherence due to a reduced pill burden (taking one tablet instead of two), a factor widely associated with better long-term cardiovascular outcomes in chronic disease management.

Key Studies & References

  1. Amlodipine/Atorvastatin Fixed-Dose Combination. A Review of its Use in the Prevention of Cardiovascular Disease and in the Treatment of Hypertension and Dyslipidemia
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Amdepin Duo (FAQ)


Q: Can I stop taking Amdepin Duo if I feel better?

A: Official information indicates that this medication is used for the chronic management of long-term health risk factors, such as high blood pressure and high cholesterol. Since these conditions require ongoing control, the drug is not intended for short-term use. Instructions about stopping or changing therapy are not detailed in standard patient documents.


Q: How long does it typically take for Amdepin Duo to start working?

A: The effects of both components generally begin within a similar timeframe. The full blood pressure-lowering effect from the Amlodipine component may become evident within two to four weeks. Similarly, the cholesterol-lowering effect from the Atorvastatin component is typically observed within two to four weeks after starting treatment.


Q: Does taking Amdepin Duo affect my ability to drive?

A: Official documents advise that this medication may cause side effects such as dizziness or drowsiness (somnolence), which can affect alertness. Due to these potential effects, patients are advised to exercise caution before driving or operating heavy machinery until they know how the medication affects them.


Q: Is there any research about Amdepin Duo in people over 65?

A: Regulatory guidelines specify use for elderly patients (age 65 and older). Due to the potential for decreased clearance of one of the drug components, a lower starting dose is sometimes indicated for this population. Official safety information also notes that advanced age is a factor that may increase the potential for muscle-related side effects.


Q: Is Amdepin Duo safe for someone with kidney issues?

A: Official documents state that dosage adjustment for the Atorvastatin component is generally not needed for patients with kidney impairment. However, caution is advised in patients with severe kidney disease. This is due to the potential for an increased risk of muscle problems.


Q: Are the side effects of Amdepin Duo temporary?

A: For some common side effects, such as headache and dizziness, official product information indicates that they are more frequently reported 'especially at the beginning of the treatment.' This observation suggests that these types of effects may potentially lessen over time as the body adjusts to the medication.


Q: Can a person with diabetes use Amdepin Duo?

A: Regulatory sources note that the statin component, Atorvastatin, has been reported to potentially increase blood glucose levels ( HbA1c and fasting serum glucose). The use of the medication in patients with pre-existing diabetes or those at risk requires clinical monitoring to manage these effects.


Q: What are the signs that Amdepin Duo is working?

A: The intended effects of the medicine are to reduce blood pressure and lower cholesterol (LDL-C). These are not usually felt by the patient. Therefore, the successful action of the medication is confirmed by objective measurements, such as regular blood pressure checks and blood tests.


Q: Will Amdepin Duo cure my high blood pressure?

A: Official prescribing information indicates that this medication is used for the long-term management of chronic conditions, including high blood pressure and high cholesterol. It is designed to help control these risk factors over time.


Q: Does Amdepin Duo cause tiredness or fatigue?

A: Yes, official documents list fatigue and asthenia (a feeling of abnormal physical weakness or lack of energy) as common adverse reactions reported during clinical trials.


Q: Are there different strengths available for Amdepin Duo?

A: Yes, the fixed-dose combination tablet is supplied in multiple different strengths. These strengths combine varying milligram amounts of the Amlodipine component and the Atorvastatin component.


Q: What kind of monitoring is needed while taking Amdepin Duo?

A: Regulatory guidance notes that monitoring is required to ensure treatment safety and effectiveness. This typically includes blood tests to check liver enzyme levels (transaminases) before starting therapy and periodically after, as well as regular monitoring of lipid levels and blood pressure.


Q: What is the typical duration of effect for a dose of Amdepin Duo?

A: The medication is prescribed for once-daily administration. This is based on the drug's design to provide sustained therapeutic action, aiming for approximately 24-hour control of both blood pressure and cholesterol levels with a single dose.


Q: What is the risk of a serious allergic reaction to Amdepin Duo?

A: Hypersensitivity (allergic) reactions are a known, though generally uncommon, risk associated with the drug. The medication is formally contraindicated (should not be used) in patients with a known allergy to the components. Signs of a serious allergic reaction require immediate medical attention.


Q: How does Amdepin Duo affect my kidneys?

A: Official safety information notes that the Atorvastatin component can, in rare instances, cause severe muscle breakdown known as rhabdomyolysis. This condition is serious because it can subsequently lead to acute kidney failure.


Q: Is Amdepin Duo a diuretic?

A: The drug is a combination of two different medicines: a dihydropyridine calcium channel blocker (amlodipine) and an HMG-CoA reductase inhibitor (atorvastatin). It is not classified as a diuretic (water pill).


Q: Can Amdepin Duo cause weight gain?

A: According to the clinical trial data for the component drugs, both weight increase and weight decrease have been reported as uncommon adverse events.


Q: Can I take pain relievers like ibuprofen with Amdepin Duo?

A: Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, may reduce the blood pressure-lowering action of the Amlodipine component. Official documents also caution that taking NSAIDs may increase the risk of serious side effects, including those related to the heart or stomach.


Q: Does Amdepin Duo interact with herbal supplements?

A: Official regulatory information directs that patients should always inform their healthcare provider about everything they are taking. This includes all prescription and over-the-counter medicines, vitamins, herbal products, and any other supplements.


Q: Is Amdepin Duo a generic or brand name drug?

A: This is a fixed-dose combination product that contains the two generic active ingredients: Amlodipine besylate and Atorvastatin calcium. This specific formulation may be marketed under various brand names, including Amdepin Duo.


Q: What should I do if I experience a rash while on Amdepin Duo?

A: Rash is listed as a potential adverse reaction. Official guidance states that patients should seek immediate medical attention if they experience signs of a serious allergic reaction, such as a rash accompanied by swelling of the face, lips, tongue, or throat.


Q: Can Amdepin Duo be used by people with asthma?

A: Asthma is not generally listed in official documents as a specific contraindication for this medication. However, as with all medications, caution is generally advised for patients with pre-existing conditions. Severe allergic reactions requiring immediate medical attention can occur with any drug.


Q: Is it true that Amdepin Duo is sometimes used after a heart event?

A: The Atorvastatin component of this medication is officially indicated for the secondary prevention of major cardiovascular events. This includes reducing the risk of a non-fatal heart attack (myocardial infarction) and fatal or non-fatal stroke in certain patients who already have clinically evident coronary heart disease.


Q: Are there any mood changes associated with Amdepin Duo?

A: According to clinical trial data for the component drugs, mood changes are listed as uncommon psychiatric adverse reactions. This includes reports of both anxiety and depression, as well as insomnia (difficulty sleeping).


Q: Is it okay to take Amdepin Duo with vitamins?

A: Official regulatory information directs that patients should always inform their healthcare provider about all products they are taking. This includes all prescription and over-the-counter medicines, vitamins, herbal products, and any other supplements.


Q: Are there studies on the long-term safety of Amdepin Duo?

A: The individual drug components are intended for long-term use in chronic disease management. Official studies indicate that the safety profile of the fixed-dose combination is comparable to that of the components taken separately, which have extensive long-term post-market safety surveillance.


Q: Does Amdepin Duo have a black box warning?

A: No, the official FDA-approved label for this specific fixed-dose combination product does not include a Black Box Warning (the most serious type of warning issued by the FDA).


Q: Is it normal to have a dry cough while taking Amdepin Duo?

A: A cough is listed as an uncommon respiratory adverse reaction in the clinical trial data for the Amlodipine component of the drug.


Q: Does Amdepin Duo have a specific use in African American patients?

A: Clinical trials for the combination product have included African American patients. Official information notes that some antihypertensive drugs, when used alone (monotherapy), may exhibit a smaller blood pressure-lowering effect in Black patients compared to non-Black patients.

Advertisements

How should Amdepin Duo be stored and disposed of?

How to Store and Dispose of Amdepin Duo?

Amdepin Duo (Amlodipine Besylate and Atorvastatin Calcium) tablets require specific conditions to ensure product stability and integrity, as defined in official regulatory labeling.

Storage Requirements

The medication must be stored at Controlled Room Temperature (CRT), maintained between 68 F to 77 F (20 C to 25 C). The tablets must be protected from light, excess heat, and moisture. It is required that the product remains in its original container, which must be kept tightly closed when not in use.

Child Safety and Disposal

As a safety measure, Amdepin Duo must be stored out of the sight and reach of children. The best method for disposing of unused or expired tablets is through an official drug take-back program. If this option is not available, the medication can be mixed with an unappealing substance, placed in a sealed bag, and discarded in household trash. The tablets must not be flushed down a toilet or sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amdepin Duo found in:

A-Z Index: